Cargando…
Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology
BACKGROUND: Parkinson’s Disease (PD) is a heterogeneous, progressive neurodegenerative disorder which is characterized by a variety of motor and non-motor symptoms. To date, no disease modifying treatment for PD exists. Here, the study protocol of the Dutch Parkinson Cohort (DUPARC) is described. DU...
Autores principales: | Boertien, Jeffrey M., van der Zee, Sygrid, Chrysou, Asterios, Gerritsen, Marleen J. J., Jansonius, Nomdo M., Spikman, Jacoba M., van Laar, Teus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293131/ https://www.ncbi.nlm.nih.gov/pubmed/32534583 http://dx.doi.org/10.1186/s12883-020-01811-3 |
Ejemplares similares
-
Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment
por: van der Zee, Sygrid, et al.
Publicado: (2022) -
Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach
por: van der Zee, Sygrid, et al.
Publicado: (2022) -
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022) -
No Dopamine Agonist Modulation of Brain [(18)F]FEOBV Binding in Parkinson’s Disease
por: Albin, Roger L., et al.
Publicado: (2022) -
Introduction: The Gut-Brain Axis in Parkinson’s Disease
por: van Laar, Teus
Publicado: (2019)